Upload Avatar (500 x 500)
Peng Ye
yp800111@163.com
English, Chinese
Hubei
Wuhan University
Medical School
  • 1998-2002 Bachelor of Pharmacy, Wuhan University
  • 2007-2009 Master of Pharmacy, Wuhan University
  • 2010-2014 PhD in Pharmacology, Huazhong University of Science and Technology
  • Published over 20 academic papers, including 10 SCI-indexed articles
  • 2002-2008 Pharmacist, Department of Pharmacy, Renmin Hospital, Wuhan University
  • 2008-2016 Chief Pharmacist, Department of Pharmacy, Renmin Hospital, Wuhan University
  • 2016-present Associate Chief Pharmacist, Department of Pharmacy, Renmin Hospital, Wuhan University
  • 2016-2018 Deputy Director, Science and Education Department, Renmin Hospital, Wuhan University
  • 2018-2019 Deputy Director, Party Committee Organization Department, Renmin Hospital, Wuhan University
  • 2019-2021 Deputy Director, Party Committee Organization Department and Party Secretary of Urology and Organ Transplantation, Renmin Hospital, Wuhan University
  • 2021-present Deputy Secretary, Party Committee of the Medical Professional Area, Renmin Hospital, Wuhan University (in charge)
  • 2018 Second Prize of Science & Technology Progress Award, Hubei Province
Drug targeting delivery systems
Antioxidant natural products activity
  • Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo, Yang T, Li B, Qi S, Liu Y, Gai Y, Ye P, Yang G, Zhang W, Zhang P, He X, Li W, Zhang Z, Xiang G, Xu C, 2014
  • Folate–PEG functionalized silica CdTe quantum dots as fluorescent probes for cancer cell imaging, Miao Lu, Wendian Zhang, Yongkang Gai, Tan Yang, Peng Ye, Guang Yang, Xiang Ma, Guangya Xiang, 2014
  • Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting, Ye P, Zhang W, Yang T, Lu Y, Lu M, Gai Y, Ma X, Xiang G, 2014
  • A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo, Huang Y, Yang T, Zhang W, Lu Y, Ye P, Yang G, Li B, Qi S, Liu Y, He X, Lee RJ, Xu C, Xiang G, 2014
  • Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes, Zhang W, Peng F, Zhou T, Huang Y, Zhang L, Ye P, Lu M, Yang G, Gai Y, Yang T, Ma X, Xiang G, 2015
  • Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance, Chen Y, Cheng Y, Zhao P, Zhang S, Li M, He C, Zhang X, Yang T, Yan R, Ye P, Ma X, Xiang G, 2018
  • Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice, Ye P, Li WL, Bao LT, Ke W, 2022
Drug Delivery Targeting Liposomes Folate Receptor Cancer Therapy Sirna Doxorubicin Imatinib Quantum Dots Cardiotoxicity

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.